Award,contract · Find a Tender
Generic Drugs - Injections/Infusions
Part of Generic Drugs - Injections/Infusions.
Find a Tender
Generic Drugs - Injections/Infusions
- Procurement
- Generic Drugs - Injections/Infusions
- Published
- 3 Aug 2022
- Status
- complete
- CPV
- 33600000 — Pharmaceutical products
- Tender period
- —
Awards
- Accord-UKactive—
- Aguettantactive—
- AOP Orphan Pharmaceuticalsactive—
- Aspen Pharmacareactive—
- B Braun Medical Ltdactive—
- Baxter Healthcareactive—
- Bowmed Ibisqusactive—
- Chiesiactive—
- Consilient Healthactive—
- CST Pharmaactive—
- Desitin Pharmaactive—
- Dr Reddy'sactive—
- Euro-Link Pharmaactive—
- Ferring Pharmaceuticalsactive—
- Focus Pharmaceuticalsactive—
- Fresenius Kabiactive—
- Glaxo Smithklineactive—
- Hameln Pharmaactive—
- Janssenactive—
- Kent Pharmaceuticalsactive—
- Martindaleactive—
- Medac Pharmaactive—
- Mercury Pharmaceuticalsactive—
- Neon Healthcareactive—
- Orion Pharmaactive—
- P M Pharmaactive—
- Panpharma UK Ltdactive—
- Pfizeractive—
- Piramal Critical Careactive—
- Sandozactive—
- Sanofiactive—
- Seacross Pharmaceuticalsactive—
- Sinteticaactive—
- Sun Pharmaactive—
- Synchrony Pharmaactive—
- Tetris Pharmaactive—
- Teva UKactive—
- Thornton & Rossactive—
- Tillomed Laboratoriesactive—
- Torbay/South Devon Healthcare NHS Foundation Trustactive—
- Viatris UK Healthcareactive—
- Wockhardt UKactive—
Other notices in this procurement
FAQs about this notice
What type of notice is this?
This is a award,contract published via Find a Tender on 3 Aug 2022.
Which procurement does this notice belong to?
It is part of "Generic Drugs - Injections/Infusions", published by Velindre NHS Trust, NHS Wales Shared Services Partnership — Procurement Services (on behalf of All Wales LHB's and Trusts.
Has this notice resulted in an award?
42 awards are recorded on this notice, including to Accord-UK.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable